Astellas Institute for Regenerative Medicine
10 clinical trials · Sponsor
◉ Watch Astellas Institute for Regenerative Medicine
| Record | Firm | Date |
|---|---|---|
| A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions (NCT07734064) | Astellas Institute for Regenerative Medicine | 2026-07-31 |
| A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration (NCT03178149) | Astellas Institute for Regenerative Medicine | 2018-07-13 |
| A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy (NCT03167203) | Astellas Institute for Regenerative Medicine | 2018-01-08 |
Track Astellas Institute for Regenerative Medicine automatically
Every clearance here is in the API, with alerts when new ones post.